Skip to content
NewsBlazeAU – Lifestyle
Author:
Lungpacer Medical USA Inc.
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
July 22, 2026
Lungpacer Medical Announces Presentation of DONATE Data Reporting an Increase in Availability of Donor Lungs
June 23, 2026
Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer
June 1, 2026